Inogen, Inc. (INGN)
USD 7.05
(-2.08%)
USD 7.05
(-2.08%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -45.67 Million USD | -208.54% |
| 2022 | -24.95 Million USD | 360.96% |
| 2021 | 30.86 Million USD | 176.84% |
| 2020 | 6.55 Million USD | -160.77% |
| 2019 | 33.62 Million USD | -47.78% |
| 2018 | 49.18 Million USD | 27.77% |
| 2017 | 39.89 Million USD | 30.47% |
| 2016 | 36.42 Million USD | -20.97% |
| 2015 | 28.76 Million USD | 174.83% |
| 2014 | 22.59 Million USD | 134.43% |
| 2013 | 13 Million USD | -24.48% |
| 2012 | 6.05 Million USD | 271.99% |
| 2011 | 1.47 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -10.2 Million USD | 53.51% |
| 2024 Q2 | -690 Thousand USD | 87.26% |
| 2023 FY | - USD | -208.54% |
| 2023 Q4 | -17.13 Million USD | -172.37% |
| 2023 Q3 | 23.68 Million USD | 417.44% |
| 2023 Q2 | -7.46 Million USD | 58.16% |
| 2023 Q1 | -17.82 Million USD | -134.41% |
| 2022 Q1 | -7.82 Million USD | -17.28% |
| 2022 Q3 | -10.29 Million USD | -446.3% |
| 2022 Q2 | 2.97 Million USD | 137.98% |
| 2022 FY | - USD | 360.96% |
| 2022 Q4 | 51.81 Million USD | 603.41% |
| 2021 Q1 | 2.96 Million USD | 153.71% |
| 2021 Q2 | 16.91 Million USD | 470.2% |
| 2021 FY | - USD | 176.84% |
| 2021 Q3 | 11.89 Million USD | -29.66% |
| 2021 Q4 | -6.67 Million USD | -156.09% |
| 2020 Q4 | -5.52 Million USD | -301.61% |
| 2020 FY | - USD | -160.77% |
| 2020 Q3 | 2.73 Million USD | 28.65% |
| 2020 Q2 | 2.12 Million USD | -6.75% |
| 2020 Q1 | 2.28 Million USD | 142.91% |
| 2019 Q1 | 7.65 Million USD | 60.25% |
| 2019 FY | - USD | -47.78% |
| 2019 Q4 | -5.32 Million USD | -145.21% |
| 2019 Q3 | 11.76 Million USD | -21.04% |
| 2019 Q2 | 14.9 Million USD | 94.79% |
| 2018 Q4 | 4.77 Million USD | -63.57% |
| 2018 FY | - USD | 27.77% |
| 2018 Q3 | 13.1 Million USD | -22.15% |
| 2018 Q2 | 16.83 Million USD | 43.99% |
| 2018 Q1 | 11.69 Million USD | 101.81% |
| 2017 FY | - USD | 30.47% |
| 2017 Q1 | 9.08 Million USD | 55.69% |
| 2017 Q2 | 12.28 Million USD | 35.23% |
| 2017 Q3 | 11.75 Million USD | -4.31% |
| 2017 Q4 | 5.79 Million USD | -50.7% |
| 2016 FY | - USD | -20.97% |
| 2016 Q1 | 6.85 Million USD | -0.2% |
| 2016 Q3 | 8.86 Million USD | -22.7% |
| 2016 Q4 | 5.83 Million USD | -34.2% |
| 2016 Q2 | 11.47 Million USD | 67.42% |
| 2015 Q2 | 8.78 Million USD | 49.67% |
| 2015 Q4 | 6.86 Million USD | -5.22% |
| 2015 Q3 | 7.24 Million USD | -17.54% |
| 2015 Q1 | 5.86 Million USD | 336.03% |
| 2015 FY | - USD | 174.83% |
| 2014 Q4 | 1.34 Million USD | -80.12% |
| 2014 Q2 | 6.9 Million USD | 63.67% |
| 2014 Q1 | 4.22 Million USD | 663.11% |
| 2014 Q3 | 6.77 Million USD | -1.97% |
| 2014 FY | - USD | 134.43% |
| 2013 Q1 | 2.5 Million USD | 43.12% |
| 2013 Q2 | 4.38 Million USD | 75.06% |
| 2013 FY | - USD | -24.48% |
| 2013 Q4 | 553 Thousand USD | -82.88% |
| 2013 Q3 | 3.23 Million USD | -26.35% |
| 2012 Q4 | 1.75 Million USD | 6.06% |
| 2012 Q3 | 1.65 Million USD | 0.0% |
| 2012 FY | - USD | 271.99% |
| 2011 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -238.689% |
| Cerus Corporation | -26.53 Million USD | -72.14% |
| OrthoPediatrics Corp. | -8.38 Million USD | -445.03% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -335.267% |
| Talis Biomedical Corporation | -66.04 Million USD | 30.837% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -173.937% |
| Spectral AI, Inc. | -12.26 Million USD | -272.525% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 4.223% |
| CVRx, Inc. | -38.73 Million USD | -17.939% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -1194.756% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -277.294% |
| Orthofix Medical Inc. | -86.98 Million USD | 47.486% |
| Venus Concept Inc. | -26.11 Million USD | -74.928% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 8.222% |
| Bioventus Inc. | -23.07 Million USD | -98.002% |
| BrainsWay Ltd. | -2.31 Million USD | -1876.59% |
| Envoy Medical, Inc. | -18.23 Million USD | -150.461% |
| electroCore, Inc. | -17.76 Million USD | -157.202% |
| IceCure Medical Ltd | -15.25 Million USD | -199.476% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 8.185% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -171.0% |
| MaxCyte, Inc. | -44.12 Million USD | -3.515% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -288.56% |
| Nexalin Technology, Inc. | -5.69 Million USD | -702.506% |
| PAVmed Inc | -75.74 Million USD | 39.691% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 15.028% |
| RxSight, Inc. | -41.03 Million USD | -11.312% |
| Sight Sciences, Inc. | -49.41 Million USD | 7.56% |
| SI-BONE, Inc. | -34.44 Million USD | -32.61% |
| TELA Bio, Inc. | -40.63 Million USD | -12.418% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 21.646% |
| Treace Medical Concepts, Inc. | -39 Million USD | -17.102% |
| LivaNova PLC | 39.01 Million USD | 217.078% |
| 908 Devices Inc. | -34.02 Million USD | -34.251% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 58.696% |
| Nemaura Medical Inc. | -7.28 Million USD | -526.851% |
| NeuroPace, Inc. | -22.83 Million USD | -100.048% |
| LENSAR, Inc. | -8.71 Million USD | -424.202% |
| Apyx Medical Corporation | -18.11 Million USD | -152.203% |
| Cutera, Inc. | -136.56 Million USD | 66.55% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -1251.45% |
| BioSig Technologies, Inc. | -28.15 Million USD | -62.264% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 1915.541% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -117.633% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 111.909% |
| Axonics, Inc. | 7.77 Million USD | 687.511% |
| Outset Medical, Inc. | -153.78 Million USD | 70.298% |
| IRIDEX Corporation | -7.44 Million USD | -513.306% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 53.434% |
| IRadimed Corporation | 20.8 Million USD | 319.604% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -466.596% |
| INVO Bioscience, Inc. | -6.88 Million USD | -563.937% |
| Telesis Bio, Inc. | -40.49 Million USD | -12.807% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 224.544% |
| Varex Imaging Corporation | 67.2 Million USD | 167.975% |
| Quipt Home Medical Corp. | 44.07 Million USD | 203.649% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -320.23% |
| Pulmonx Corporation | -55.09 Million USD | 17.086% |
| Dynatronics Corporation | -976 Thousand USD | -4580.187% |
| Modular Medical, Inc. | -17.1 Million USD | -167.082% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -215.354% |
| Semler Scientific, Inc. | 23.58 Million USD | 293.645% |
| InMode Ltd. | 196.28 Million USD | 123.272% |
| Bruker Corporation | 599 Million USD | 107.626% |
| Cytosorbents Corporation | -28.81 Million USD | -58.548% |
| DexCom, Inc. | 916.7 Million USD | 104.983% |
| Align Technology, Inc. | 799.03 Million USD | 105.717% |
| Viveve Medical, Inc. | -20.61 Million USD | -121.56% |
| ZimVie Inc. | 91.07 Million USD | 150.156% |
| Movano Inc. | -29.12 Million USD | -56.838% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -936.275% |
| Nexalin Technology, Inc. | -5.69 Million USD | -702.506% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -1194.756% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 76.534% |
| Profound Medical Corp. | -27.12 Million USD | -68.411% |
| Insulet Corporation | 323.6 Million USD | 114.116% |
| enVVeno Medical Corporation | -25.01 Million USD | -82.585% |
| Surmodics, Inc. | 1.18 Million USD | 3945.034% |
| iCAD, Inc. | -6.56 Million USD | -595.796% |
| Nuwellis, Inc. | -16.35 Million USD | -179.28% |
| Biotricity, Inc. | -8.82 Million USD | -417.417% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 52.841% |
| Aethlon Medical, Inc. | -11.84 Million USD | -285.506% |
| InspireMD, Inc. | -20.91 Million USD | -118.445% |
| PAVmed Inc. | -75.74 Million USD | 39.691% |
| BIOLASE, Inc. | -15.13 Million USD | -201.731% |
| Beyond Air, Inc. | -59.03 Million USD | 22.619% |
| FONAR Corporation | 28.25 Million USD | 261.687% |
| AxoGen, Inc. | -13.32 Million USD | -242.73% |
| Vivani Medical, Inc. | -26.6 Million USD | -71.674% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 286.133% |
| Inari Medical, Inc. | 7.11 Million USD | 742.19% |
| UFP Technologies, Inc. | 72.74 Million USD | 162.795% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -1249.14% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -642.025% |
| Tenon Medical, Inc. | -15.52 Million USD | -194.172% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -199.22% |
| Co-Diagnostics, Inc. | -41.47 Million USD | -10.134% |
| AdaptHealth Corp. | -171.09 Million USD | 73.301% |
| Sintx Technologies, Inc. | -6.6 Million USD | -592.106% |
| NanoVibronix, Inc. | -3.43 Million USD | -1229.811% |
| Quanterix Corporation | -38.08 Million USD | -19.93% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -320.23% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 152363.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 83.526% |
| TransMedics Group, Inc. | -7.6 Million USD | -500.802% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -109.874% |
| NeuroMetrix, Inc. | -7.09 Million USD | -543.746% |
| Hyperfine, Inc. | -47.06 Million USD | 2.937% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 21.658% |
| Biomerica, Inc. | -5.99 Million USD | -662.206% |
| Bone Biologics Corporation | 479.57 Thousand USD | 9624.951% |
| AVITA Medical, Inc. | -39.56 Million USD | -15.445% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -397.976% |
| Silk Road Medical, Inc | -45.08 Million USD | -1.329% |